256 related articles for article (PubMed ID: 11986950)
1. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
Shimada H; Ichikawa H; Ohki M
Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
[TBL] [Abstract][Full Text] [Related]
2. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF.
Shimada H; Ichikawa H; Nakamura S; Katsu R; Iwasa M; Kitabayashi I; Ohki M
Blood; 2000 Jul; 96(2):655-63. PubMed ID: 10887131
[TBL] [Abstract][Full Text] [Related]
3. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
4. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon.
Shimizu K; Kitabayashi I; Kamada N; Abe T; Maseki N; Suzukawa K; Ohki M
Blood; 2000 Jul; 96(1):288-96. PubMed ID: 10891464
[TBL] [Abstract][Full Text] [Related]
5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
6. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
[TBL] [Abstract][Full Text] [Related]
7. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
8. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
[TBL] [Abstract][Full Text] [Related]
12. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
13. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
Fukuyama T; Kitamura T; Kozu T
Int J Hematol; 2022 May; 115(5):686-693. PubMed ID: 35152350
[TBL] [Abstract][Full Text] [Related]
14. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
15. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.
Kitabayashi I; Ida K; Morohoshi F; Yokoyama A; Mitsuhashi N; Shimizu K; Nomura N; Hayashi Y; Ohki M
Mol Cell Biol; 1998 Feb; 18(2):846-58. PubMed ID: 9447981
[TBL] [Abstract][Full Text] [Related]
16. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
[TBL] [Abstract][Full Text] [Related]
17. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.
Heidenreich O; Krauter J; Riehle H; Hadwiger P; John M; Heil G; Vornlocher HP; Nordheim A
Blood; 2003 Apr; 101(8):3157-63. PubMed ID: 12480707
[TBL] [Abstract][Full Text] [Related]
18. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
Yuan Y; Zhou L; Miyamoto T; Iwasaki H; Harakawa N; Hetherington CJ; Burel SA; Lagasse E; Weissman IL; Akashi K; Zhang DE
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10398-403. PubMed ID: 11526243
[TBL] [Abstract][Full Text] [Related]
19. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
20. Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).
Matsushita H; Kobayashi H; Mori S; Kizaki M; Ikeda Y
Biochem Biophys Res Commun; 1995 Oct; 215(2):431-7. PubMed ID: 7487974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
